Prev Close | 70.41 |
Day Low/High | 67.88 / 72.46 |
52 Wk Low/High | 26.49 / 85.00 |
Prev Close | 70.41 |
Day Low/High | 67.88 / 72.46 |
52 Wk Low/High | 26.49 / 85.00 |
Exchange | NASDAQ |
Shares Outstanding | 257.66B |
Market Cap | 18.14B |
P/E Ratio | 17.98 |
Div & Yield | N.A. (N.A) |
It's time to take some profits on the company's success.
Hologic is seeing huge demand for its 3-D mammography machines and it is still early in the adoption cycle, said Leah Bennett, Co-Chief Investment Officer for South Texas Money Management.
Underlying fundamentals are in place for a healthy stock market.
Here's what we'd be buying into weakness for 2015.
Invest in companies whose management teams inspire confidence.
Investing during a mid-term election can offer large returns.
There is a disconnect between stock prices and intrinsic value.
The Carl Icahn lesson. "Also-Ran Surprise No. 5: Carl Icahn's fund loses 15% to 20%." --Ā Kass Diary, 15 Surprises for 2014. By my calculation (below) Carl Icahn's portfolio (of individual stock holdings) has lost more than $6 billionĀ from the recent...
Corporate activism should continue to be a positive for stock prices.
Hologic, Symantec and TE Connectivity could all benefit from the current M&A binge.
Spice up your portfolio with some takeover bait.
Six stocks poised to deliver favorable returns for the balance of the year.
Positive developments and an attractive entry point make the stock a table-pounding buy.
Buy the dips and don't chase the rallies.
Let's review.
They should improve shareholder value in coming months.
Hologic should benefit from a greater sense of urgency.
Buying based on price in a mature bull market is not a recipe for success. Subscriber HG, thanks for the Stifel report onĀ HologicĀ (HOLX). I am passing on this name as there appears to be no catalyst over the near term. Buying based on price in a mat...
Hologic's price target gets trimmed. Citigroup reiterates its neutral rating on Hologic (HOLX) but lowers its price target by $2 per share to $22. Staying away.
After its miss, is it a value? Is there anyone on site who has a fundamental view of Hologic (HOLX)? This is an old name I have been long from in the past, and it used to be a large Omega Advisors holding. Prima facie, it looks like value despite th...